Stripping patent protection from Covid-19 treatments is a “mind-bogglingly stupid” idea, the head of a leading pharmaceutical lobby said Wednesday, warning that the move would put industry innovation at risk.
Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), said the industry was still working on more effective Covid vaccines and treatments.